An underground economy for unapproved slimming drugs is propelled by TikTok fitness influencers and vendors on communication apps, based on recent findings.
Experimental Treatment Gaining Popularity Via Social Media
The experimental drug, which is still in research studies, is being promoted by online personalities for its alleged fat-burning properties. Viewers are encouraged to contact these accounts directly for supplier links, while also obtaining discount codes.
Thriving Trade on Social Networks
Additionally, a robust market exists on messaging services, where groups with thousands of participants share “before and after” photos, injection guides and claims of rapid British shipping. Vendors promote the substance there before directing buyers to WhatsApp for transactions.
Understanding Retatrutide
Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could assist patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Medical Experts Voice Concerns
Nevertheless, doctors and chemists have cautions that the distribution of what is still an unlicensed medication in the United Kingdom is a cause for concern and could result in users injecting products of uncertain source.
Some professionals said the demand for the experimental drug could be connected to the increasing price of approved weight loss products such as Mounjaro.
Regulatory Status and Implementation
Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unlicensed medication that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Several content creators try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still violate pharmaceutical, marketing, and customer laws, risking fines, prosecution or imprisonment.
Platform Reaction and Material Removal
According to TikTok, the service has removed violative material and prohibited associated keywords and search suggestions. The company said it was committed to keeping the service safe and investing in enhancing compliance measures.
Online Trading Activities
Investigations also discovered groups with up to nine thousand participants selling the experimental drug using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately displays channels with numerous of members, filled with images of weight loss, glowing testimonials and step-by-step instructions for preparing or injecting at residence.
After minutes of entering one group, a vendor posted WhatsApp details, where most purchases occur. The vendor provided an instruction manual and guaranteed shipping within two days. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a image of a supposed testing documentation. None asked about body mass, medical conditions or past usage.
Item Details and Costs
Inside these groups, posts display black plastic parcels with postal service stickers, claiming to include new batches. One message read: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, prepared at home with sterile water, or pre-filled injectors usually sold at 160 pounds for 20mg. When questioned how much time a pen should last, sellers give contradictory responses varying between a few weeks to “depends on your body”.
Service Oversight and Security Measures
A spokesperson for Telegram said it actively moderated dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are injecting materials they can’t verify. Even if the research behind this drug is sound, these online products may not contain what they claim,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.
A medical professional of an online medical service connected the surge in interest to current price rises for authorized slimming medications such as Mounjaro. “With prices increasing, individuals are using social media. But fake treatments are highly dangerous. You cannot know what’s contained or whether the environment they were produced in was sterile,” she said.
Her team has previously encountered individuals harmed by self-injection from unverified sources. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These materials could be impure or improperly measured.”
Producer Statement
A representative from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for human use,” they explained, noting that any product “falsely representing itself as a Lilly investigational substance not yet authorized … may expose users to possibly serious health risks”.
